Friday, January 20, 2017 11:28:59 AM
He's an Independent Medical Devices Professional
As the Co-Founder of Acceptent and founder of AMG Development a medical device consulting firm, his professional experience includes many different areas ranging from product management to executive management for over ten start-up entities.
He founded MedTrek an innovative surgical company which partnered with Olympus worldwide. He was later chief operating officer for start-up Acueity Healthcare, a revolutionary technology for early detection of breast cancer. Acueity was featured in Time magazine as one of the top five medical technologies for breast cancer detection and treatment.
Since Acueity, he has been an executive advisor to startup entities; Acclarent, Inc. (acquired by Johnson & Johnson). He has served as CEO for medical start-up Sanomedics and helped launch its line of patient diagnostic devices. In addition, he served as President and on the board of directors of Solos Endoscopy - SNDY.
During his career, he has developed, launched and successfully managed over 75 medical devices ranging from polymer based disposables to integrated imaging systems. He holds 7 patents and is co-inventor on three patent pending medical devices.
Mr. Gatto graduated Magna Cum Laude with a BS degree in Marketing from Quinnipiac University and attended the Executive Management program at the John E. Anderson School of Business – UCLA. He is currently a judge, mentor and Entrepreneur-in-Residence at The University of Notre Dame’s Mendoza School of Business. Also, he recently became an entrepreneurial advisor for the NFL Player Engagement Program.
https://www.linkedin.com/in/dom-gatto-b68aa95?authType=NAME_SEARCH&authToken=XIq_&locale=en_US&trk=tyah&trkInfo=clickedVertical%3Amynetwork%2CclickedEntityId%3A17642816%2CauthType%3ANAME_SEARCH%2Cidx%3A1-1-1%2CtarId%3A1484683942948%2Ctas%3ADom%20Gatto
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM